GO:0030506 ankyrin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030506 ankyrin binding describes the molecular function of selectively binding to ankyrin, a ~200 kDa cytoskeletal adaptor protein that links integral membrane proteins to the spectrin-based cytoskeleton.
• Ankyrin binding is mediated by conserved ankyrin-binding domains, including the spectrin-binding domain of ankyrins and the ankyrin-binding motifs of partner proteins such as betaII-spectrin and TRAAK.
• The interaction between ankyrin and beta-spectrin is essential for neuronal function, and its disruption by alpha-synuclein contributes to neurodegeneration.
• Ankyrin-G and its binding partners orchestrate the molecular structure of the axon initial segment, a critical domain for action potential initiation and neuronal polarity.
• Obscurin regulates ankyrin macromolecular complex formation in cardiac muscle, highlighting the role of ankyrin binding in tissue-specific cytoskeletal organization.
• Poxviral ankyrin proteins contain ankyrin repeats and may modulate host ankyrin-dependent processes, illustrating pathogen exploitation of ankyrin binding.
Description
Ankyrin binding (GO:0030506) is a molecular function defined as the selective interaction with ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins. Ankyrins are adaptor proteins that link the spectrin-based membrane skeleton to various ion channels, transporters, and cell adhesion molecules, thereby organizing specialized membrane domains. The binding of ankyrin to its partners is fundamental to cellular architecture, particularly in excitable tissues such as neurons and cardiac muscle. Researchers study ankyrin binding to understand how cells establish and maintain polarized domains, such as the axon initial segment (AIS) in neurons, which is essential for action potential initiation and neuronal polarity. The interaction between ankyrin and beta-spectrin is a key example, and its disruption has been linked to neuronal dysfunction and death in synucleinopathies. Additionally, ankyrin binding is implicated in cardiac function through obscurin, which regulates ankyrin macromolecular complex formation. Viral proteins, such as poxviral ankyrin proteins, can also interact with ankyrin-binding pathways, suggesting a role in host-pathogen interactions. Given its importance, ankyrin binding is a subject of intense research, with methods ranging from structural biology to CRISPR-based gene editing. Understanding the molecular details of ankyrin binding can provide insights into diseases such as neurodegeneration and cardiac disorders, and may reveal new therapeutic targets.
ankyrin binding At A Glance
| GO ID | GO:0030506 |
|---|---|
| GO term | ankyrin binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins. |
| Definition source | QuickGO |
| Related cellular component | Spectrin-based membrane skeleton, axon initial segment |
| Related biological process | Cytoskeletal organization, membrane domain assembly, neuronal polarity |
| Example binding partners | BetaII-spectrin, TRAAK, obscurin |
What Is GO:0030506?
Ankyrin binding (GO:0030506) is the molecular function of binding to ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins. This function is typically mediated by specific ankyrin-binding domains or motifs present in partner proteins, such as the spectrin-binding domain of ankyrins or the ankyrin-binding motif of TRAAK.
Why Is ankyrin binding Important in Cell Biology?
Ankyrin binding is crucial for maintaining cellular architecture and organizing specialized membrane domains, particularly in neurons and cardiac muscle. Disruption of ankyrin binding can lead to severe physiological consequences, such as neuronal dysfunction and death in neurodegenerative diseases. Moreover, pathogens like poxviruses encode ankyrin-repeat proteins that may interfere with host ankyrin-dependent processes, underscoring the broad biological significance of this interaction.
• Essential for the assembly and maintenance of the axon initial segment, a key neuronal domain for action potential initiation.
• Disruption of ankyrin-beta-spectrin binding by alpha-synuclein contributes to neuronal dysfunction and death in synucleinopathies.
• Obscurin regulates ankyrin macromolecular complex formation in cardiac muscle, affecting heart function.
• Ankyrin binding is involved in the localization of ion channels and transporters, influencing cellular excitability.
• Poxviral ankyrin proteins may modulate host immune responses by interacting with ankyrin-binding pathways.
• Mutations in genes encoding ankyrin-binding partners can cause diseases such as hereditary spherocytosis and cardiac arrhythmias.
• Ankyrin binding is a potential therapeutic target for neurodegenerative and cardiovascular diseases.
• Understanding ankyrin binding aids in the development of CRISPR-based models for studying cytoskeletal disorders.
What Happens During ankyrin binding?
Recognition and Binding to Ankyrin
In simple terms: Ankyrin binding starts when a partner protein recognizes and attaches to ankyrin.
The process begins with the specific recognition of ankyrin by a partner protein containing an ankyrin-binding domain. For example, betaII-spectrin binds to ankyrin via its ankyrin-binding domain, a interaction that is critical for linking the spectrin cytoskeleton to the plasma membrane. Similarly, the TRAAK potassium channel contains an ankyrin-G-binding motif that mediates its periodic localization at axon initial segments. This binding is highly specific and is governed by the structural complementarity between the ankyrin-binding domain and ankyrin's interaction surface.
Formation of Macromolecular Complexes
In simple terms: After binding, ankyrin and its partners assemble into larger protein complexes.
Once ankyrin binds to its partner, it can nucleate the formation of macromolecular complexes. For instance, obscurin regulates the formation of ankyrin macromolecular complexes in cardiac muscle, which are essential for maintaining sarcomeric structure and function. In neurons, ankyrin-G recruits multiple binding partners, including ion channels and cell adhesion molecules, to the axon initial segment, forming a dense protein network that is crucial for neuronal polarity. These complexes are dynamic and can be regulated by various factors, including phosphorylation and alternative splicing.
Anchoring to the Cytoskeleton and Membrane
In simple terms: The complex anchors to the cytoskeleton and the cell membrane, providing structural support.
Ankyrin binding serves to anchor integral membrane proteins to the underlying spectrin-based cytoskeleton. Ankyrin itself binds to spectrin, and through its interactions with partner proteins, it connects them to the membrane skeleton. This anchoring is vital for maintaining the stability and integrity of specialized membrane domains, such as the axon initial segment and the cardiac sarcolemma. Disruption of this anchoring can lead to loss of membrane domain organization and cellular dysfunction.
Regulation and Dynamics
In simple terms: Ankyrin binding is regulated to allow dynamic changes in cell structure.
Ankyrin binding is not static; it is regulated by various mechanisms. For example, alpha-synuclein can disrupt the binding of ankyrin to beta-spectrin, leading to neuronal dysfunction. Additionally, post-translational modifications and interactions with other proteins, such as obscurin, can modulate ankyrin complex formation. The dynamic nature of ankyrin binding allows cells to remodel their cytoskeleton and membrane domains in response to developmental or physiological cues.
Key Genes Involved in GO:0030506 ankyrin binding
The following genes encode proteins that are directly involved in ankyrin binding or are key components of ankyrin-dependent complexes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ANK1 | Encodes ankyrin-1, a cytoskeletal adaptor protein that binds spectrin and integral membrane proteins | Mutations cause hereditary spherocytosis; studied for red blood cell membrane stability |
| ANK2 | Encodes ankyrin-2, involved in neuronal and cardiac function | Linked to cardiac arrhythmias and neuronal disorders |
| ANK3 | Encodes ankyrin-G, critical for axon initial segment assembly | Key for neuronal polarity and action potential initiation |
| SPTBN1 | Encodes betaII-spectrin, binds ankyrin via its ankyrin-binding domain | Essential for cytoskeletal organization; studied in neuronal and membrane biology |
| SPTAN1 | Encodes alphaII-spectrin, forms heterodimers with beta-spectrin and interacts with ankyrin | Mutations cause early infantile epileptic encephalopathy |
| KCNK4 | Encodes TRAAK, a potassium channel with an ankyrin-G-binding motif | Mediates TRAAK localization at axon initial segments |
| OBSCN | Encodes obscurin, regulates ankyrin macromolecular complex formation | Involved in cardiac muscle function and disease |
| SNCA | Encodes alpha-synuclein, disrupts ankyrin-beta-spectrin binding | Implicated in Parkinson's disease and other synucleinopathies |
| ANKFY1 | Encodes ankyrin repeat and FYVE domain-containing protein 1 | May be involved in endosomal trafficking and ankyrin-related functions |
| ANKRD1 | Encodes cardiac ankyrin repeat protein, interacts with titin and may modulate ankyrin complexes | Studied in cardiac hypertrophy and heart failure |
| ANKRD2 | Encodes ankyrin repeat domain 2, a muscle-specific protein | Potential role in muscle cytoskeleton |
| TRPV4 | Encodes a mechanosensitive ion channel that can interact with ankyrin | Involved in mechanotransduction and cytoskeletal interactions |
| NCAM1 | Encodes neural cell adhesion molecule 1, binds ankyrin | Important for neuronal development and synaptic plasticity |
| L1CAM | Encodes L1 cell adhesion molecule, binds ankyrin | Mutations cause L1 syndrome; studied in neuronal migration |
| RHAG | Encodes Rh-associated glycoprotein, interacts with ankyrin-1 | Critical for red blood cell membrane integrity |
| SLC4A1 | Encodes band 3 anion exchanger, binds ankyrin-1 | Mutations cause hereditary spherocytosis and distal renal tubular acidosis |
| KCNQ2 | Encodes a potassium channel that binds ankyrin-G | Linked to benign familial neonatal seizures |
| SCN8A | Encodes Nav1.6 sodium channel, binds ankyrin-G | Mutations cause epilepsy and movement disorders |
How Is ankyrin binding Regulated?
Ankyrin binding is regulated at multiple levels. Post-translational modifications, such as phosphorylation, can modulate the affinity between ankyrin and its partners. For example, the binding of ankyrin to beta-spectrin can be disrupted by alpha-synuclein, which is implicated in neurodegeneration. Additionally, obscurin regulates the formation of ankyrin macromolecular complexes in cardiac muscle, suggesting that tissue-specific factors control ankyrin binding dynamics. Alternative splicing of ankyrin genes also generates diverse isoforms with distinct binding properties, further fine-tuning the interactions.
ankyrin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SNCA | Parkinson's disease, synucleinopathies | Knockout or point-mutation of SNCA in neurons to study ankyrin-beta-spectrin disruption |
| ANK1 | Hereditary spherocytosis | Knockout of ANK1 in erythroid cell lines or patient-derived iPSCs |
| ANK2 | Cardiac arrhythmias (long QT syndrome) | Knock-in of ANK2 mutations in cardiomyocytes derived from iPSCs |
| OBSCN | Cardiomyopathy | Knockout of OBSCN in cardiac muscle cells to study ankyrin complex formation |
| KCNK4 | Neuronal excitability disorders | Knock-in of TRAAK ankyrin-binding motif mutations in hippocampal neurons |
Neurodegeneration and Synucleinopathies
Disruption of ankyrin binding is a key event in neurodegeneration. Alpha-synuclein, the major component of Lewy bodies in Parkinson's disease, promotes neuronal dysfunction and death by disrupting the binding of ankyrin to beta-spectrin. This disruption leads to the loss of cytoskeletal integrity at the axon initial segment and subsequent neuronal dysfunction. Furthermore, ankyrin-G and its binding partners are essential for axon initial segment structure, and their dysfunction has been linked to various neurological disorders.
Cardiac Disorders
Ankyrin binding is critical for cardiac muscle function. Obscurin regulates ankyrin macromolecular complex formation in the heart, and mutations in OBSCN have been associated with cardiomyopathies. Additionally, ankyrin-2 (ANK2) mutations can cause cardiac arrhythmias, such as long QT syndrome and atrial fibrillation, by disrupting the localization of ion channels and transporters.
Hereditary Spherocytosis and Red Blood Cell Disorders
Ankyrin-1 (ANK1) mutations are a common cause of hereditary spherocytosis, a red blood cell membrane disorder characterized by spherical erythrocytes and hemolytic anemia. Ankyrin-1 binds to beta-spectrin and band 3, and defects in these interactions lead to membrane instability and premature red blood cell destruction.
Viral Pathogenesis
Poxviral ankyrin proteins contain ankyrin repeats and can interact with host ankyrin-binding pathways, potentially modulating immune responses and contributing to viral pathogenesis. Understanding how these viral proteins engage ankyrin binding may reveal new antiviral strategies.
From ankyrin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ankyrin binding disruption on neuronal polarity? | Knockout of ANK3 in primary hippocampal neurons |
| How does alpha-synuclein disrupt ankyrin-beta-spectrin binding? | Point mutation of SNCA (e.g., A53T) in neuronal cell lines |
| What is the role of obscurin in cardiac ankyrin complex formation? | Knockout of OBSCN in cardiomyocytes |
| How does the TRAAK ankyrin-binding motif affect channel localization? | Knock-in of mutated KCNK4 in hippocampal pyramidal neurons |
| What is the structural basis of spectrin-ankyrin interaction? | Overexpression of recombinant spectrin and ankyrin domains in E. coli for crystallography |
| Can ankyrin binding be modulated by post-translational modifications? | Point mutation of phosphorylation sites in ANK1 or SPTBN1 in cell lines |
How to Study the ankyrin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of protein complexes | Determining the structure of spectrin-ankyrin binding domains |
| GST pull-down | Direct protein-protein interaction | Identifying ankyrin-binding partners |
| Co-immunoprecipitation | Endogenous protein complexes | Detecting disruption of ankyrin-beta-spectrin binding by alpha-synuclein |
| Live-cell imaging | Subcellular localization and dynamics | Visualizing TRAAK at axon initial segments |
| CRISPR knockout screen | Gene function on a genome-wide scale | Identifying regulators of ankyrin binding |
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Quantifying ankyrin-spectrin interaction |
| Proteomics (mass spectrometry) | Protein composition of complexes | Identifying components of ankyrin macromolecular complexes |
| Electrophysiology | Ion channel function | Assessing the impact of ankyrin binding on channel activity |
Structural Biology (X-ray Crystallography and Cryo-EM)
Structural biology techniques such as X-ray crystallography and cryo-electron microscopy are used to determine the atomic details of ankyrin binding. For example, the structures of the spectrin-ankyrin interaction binding domains have been solved, revealing the molecular basis of this interaction. These methods provide insights into how mutations affect binding affinity and specificity.
Biochemical Binding Assays (GST Pull-down, Co-IP)
Biochemical assays like GST pull-down and co-immunoprecipitation (co-IP) are used to detect and quantify ankyrin binding. These methods can identify novel binding partners and assess the effects of mutations on binding. For instance, co-IP has been used to show that alpha-synuclein disrupts the binding of ankyrin to beta-spectrin.
Live-Cell Imaging and Fluorescence Microscopy
Live-cell imaging with fluorescently tagged proteins allows researchers to visualize ankyrin binding dynamics in real time. This approach has been used to study the periodic localization of TRAAK at axon initial segments, which depends on its ankyrin-G-binding motif. Fluorescence recovery after photobleaching (FRAP) can measure binding turnover.
CRISPR-Based Genetic Screens
CRISPR knockout and knock-in screens can identify genes that regulate ankyrin binding. For example, a genome-wide knockout screen could reveal modifiers of ankyrin-beta-spectrin binding in neurons. These screens are powerful for discovering novel components of ankyrin-dependent pathways.
How CRISPR Can Be Used to Study GO:0030506 ankyrin binding
Knockout
CRISPR knockout is used to delete genes encoding ankyrin or its binding partners to study loss-of-function phenotypes. For example, knocking out ANK3 in neurons disrupts axon initial segment assembly and neuronal polarity. Similarly, ANK1 knockout in erythroid cells impairs membrane stability and causes spherocytosis-like defects. These models are valuable for understanding the essential roles of ankyrin binding in cellular physiology.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect the functional domains of ankyrin-binding proteins. For instance, mutating the ankyrin-binding motif of TRAAK (KCNK4) can abolish its localization at axon initial segments, revealing the importance of this motif. Point mutations in SNCA that mimic disease-associated variants can be used to study how alpha-synuclein disrupts ankyrin binding.
Knock-in
CRISPR knock-in allows the introduction of tagged or reporter versions of ankyrin-binding proteins to track their localization and interactions. For example, knocking in a fluorescent tag on ANK3 enables live-cell imaging of ankyrin-G dynamics at the axon initial segment. Knock-in of disease-associated mutations in ANK2 can model cardiac arrhythmias in cardiomyocytes.
Overexpression
CRISPR overexpression (e.g., via CRISPR activation) can increase the levels of ankyrin-binding proteins to study their effects on cellular structure. Overexpressing betaII-spectrin or its ankyrin-binding domain can saturate binding sites and disrupt endogenous complexes, providing insights into stoichiometry. Overexpression of obscurin can enhance ankyrin complex formation in cardiac cells.
How EDITGENE Supports ankyrin binding Research
Researchers studying ankyrin binding-related genes often need to determine whether a candidate gene is causally involved in cytoskeletal organization, neuronal function, or disease. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for ankyrin binding research.
Frequently Asked Questions About ankyrin binding
What is ankyrin binding?
Ankyrin binding (GO:0030506) is the molecular function of selectively binding to ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins.
What genes are involved in ankyrin binding?
Key genes include ANK1, ANK2, ANK3 (encoding ankyrins), SPTBN1 (betaII-spectrin), KCNK4 (TRAAK), OBSCN (obscurin), and SNCA (alpha-synuclein).
How does ankyrin binding affect neuronal function?
Ankyrin binding is essential for the assembly of the axon initial segment, a domain critical for action potential initiation and neuronal polarity. Disruption leads to neuronal dysfunction.
What diseases are associated with ankyrin binding?
Diseases include hereditary spherocytosis (ANK1 mutations), cardiac arrhythmias (ANK2 mutations), neurodegeneration (alpha-synuclein disrupting ankyrin binding), and cardiomyopathies (OBSCN mutations).
What is the role of betaII-spectrin in ankyrin binding?
BetaII-spectrin binds to ankyrin via its ankyrin-binding domain, linking the spectrin cytoskeleton to the plasma membrane. This interaction is crucial for membrane stability.
How is ankyrin binding regulated?
Ankyrin binding is regulated by post-translational modifications, alternative splicing, and protein-protein interactions. For example, alpha-synuclein disrupts ankyrin-beta-spectrin binding.
What methods are used to study ankyrin binding?
Common methods include X-ray crystallography, GST pull-down, co-immunoprecipitation, live-cell imaging, and CRISPR-based screens.
Can CRISPR be used to study ankyrin binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of ankyrin-binding proteins in cells.
What is the axon initial segment and how does ankyrin binding relate to it?
The axon initial segment is a specialized neuronal domain enriched in ankyrin-G and its binding partners. Ankyrin binding is required for its assembly and function.
How does alpha-synuclein affect ankyrin binding?
Alpha-synuclein promotes neuronal dysfunction and death by disrupting the binding of ankyrin to beta-spectrin, leading to cytoskeletal disorganization.
Conclusion
Ankyrin binding (GO:0030506) is a fundamental molecular function that underpins cytoskeletal organization and membrane domain assembly, with critical roles in neurons, cardiac muscle, and red blood cells. Disruption of ankyrin binding is implicated in a range of human diseases, from neurodegeneration to hereditary spherocytosis. Continued research using advanced CRISPR models and structural techniques will further illuminate the molecular details and therapeutic potential of targeting ankyrin interactions.
References
- 1. Zhu X et al.. 2025. Ankyrin-G and Its Binding Partners in Neurons: Orchestrating the Molecular Structure of the Axon Initial Segment.. Biomolecules 15(6) PMID: 40563541
- 2. Bok E et al.. 2007. Lipid-binding role of betaII-spectrin ankyrin-binding domain.. Cell Biol Int 31(12):1482-94 PMID: 17716929
- 3. Luque-Fernández V et al.. 2024. An ankyrin G-binding motif mediates TRAAK periodic localization at axon initial segments of hippocampal pyramidal neurons.. Proc Natl Acad Sci U S A 121(31):e2310120121 PMID: 39058579
- 4. Herbert MH et al.. 2015. Poxviral ankyrin proteins.. Viruses 7(2):709-38 PMID: 25690795
- 5. Maor G et al.. 2023. α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin.. J Neurosci 43(9):1614-1626 PMID: 36653193
- 6. Bennett V et al.. 1985. Ankyrin and synapsin: spectrin-binding proteins associated with brain membranes.. J Cell Biochem 29(2):157-69 PMID: 2933418
- 7. Subramaniam J et al.. 2022. Obscurin regulates ankyrin macromolecular complex formation.. J Mol Cell Cardiol 168:44-57 PMID: 35447147
- 8. Ipsaro JJ et al.. 2009. Structures of the spectrin-ankyrin interaction binding domains.. Blood 113(22):5385-93 PMID: 19141864
